ACSM5 and Lassa fever: To further confirm that ACSM5 delayed LF hypertrophy by inhibiting FABP4-mediated PPARγ signaling pathway, a mouse model of LF hypertrophy, which is highly consistent with human clinical features, was constructed using hydrophobic property.